Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medifast (MED) Other Non Operating Income (2016 - 2025)

Medifast's Other Non Operating Income history spans 16 years, with the latest figure at $1000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 100.26% year-over-year to $1000.0; the TTM value through Dec 2025 reached $3.1 million, up 178.49%, while the annual FY2025 figure was $3.1 million, 178.51% up from the prior year.
  • Other Non Operating Income reached $1000.0 in Q4 2025 per MED's latest filing, up from -$2000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $2.6 million in Q2 2025 to a low of -$4.1 million in Q2 2024.
  • Average Other Non Operating Income over 5 years is -$43000.0, with a median of -$3000.0 recorded in 2022.
  • The largest YoY upside for Other Non Operating Income was 242300.0% in 2024 against a maximum downside of 26685.71% in 2024.
  • A 5-year view of Other Non Operating Income shows it stood at $7000.0 in 2021, then crashed by 228.57% to -$9000.0 in 2022, then tumbled by 455.56% to -$50000.0 in 2023, then crashed by 674.0% to -$387000.0 in 2024, then surged by 100.26% to $1000.0 in 2025.
  • Per Business Quant, the three most recent readings for MED's Other Non Operating Income are $1000.0 (Q4 2025), -$2000.0 (Q3 2025), and $2.6 million (Q2 2025).